Please assess the completion status of the following clinical trial:

Trial Title: Diclofenac for the Prevention of Post-ERCP Pancreatitis in Higher Risk Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~These were chosen based on a review of the major studies evaluating risk factors for post-ERCP pancreatitis. Any of the following factors placing a patient at high risk (\>10%) of post ERCP pancreatitis:~* Patient characteristics: Prior history of post-ERCP pancreatitis, prior history of acute pancreatitis, suspected Sphincter of Oddi dysfunction, or normal bilirubin;~* Procedure related factors: Moderate (6-15 attempts) and difficult (\>15 attempts) bile duct cannulation, balloon dilation of the biliary sphincter, pre-cut papillotomy, pancreatic sphincterotomy.~Exclusion Criteria:~* Ongoing acute or chronic pancreatitis;~* Previous biliary sphincterotomy;~* Contra-indications to non-steroidal anti-inflammatory medications (allergy, reduced renal function, recent upper gastrointestinal bleeding);~* Ingestion of an NSAID ( nonsteroidal anti-inflammatory drug) in the previous 7 days.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- placebo suppository (Type: PLACEBO_COMPARATOR): None
- diclofenac suppository (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).